Hematology analyser provides near native-state cellular characterization

Hematology analyser provides near native-state cellular characterization

Beckman Coulter recently announced the release of the DxH 900 hematology analyser, giving mid- to high-volume clinical laboratories the ability to perform complete blood count (CBC) and white blood cell...

Supplied by Beckman Coulter Inc


Beckman Coulter recently announced the release of the DxH 900 hematology analyser, giving mid- to high-volume clinical laboratories the ability to perform complete blood count (CBC) and white blood cell differential tests with minimal repeats. The DxH 900 is now available for sale in Europe, the United States, Canada, Australia and New Zealand. The DxH 900 analyser offers advanced technologies to support patient care, by delivering the right results the first time. Foundational to the system are its core technologies, including the enhanced Coulter Principle, VCS 360 and DataFusion. These features offer high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for excellent red blood cell, platelet and white blood cell test results on the first pass. The suite of technologies is intended to help laboratories deliver quality results for fast, accurate clinical decision-making. At the same time, the system includes automated solutions that streamline the number of procedural steps needed to produce those results, offering predictable performance and greater laboratory efficiency. The DxH 900 analyser demonstrates 93% first-pass throughput, providing accurate flagging and reducing the number of slide reviews. This helps to generate reportable results as quickly as possible, reducing the time, supplies and costs that may be required for systems with higher repeat rates. Adding to this is the analyser’s lean reagent portfolio, which includes four reagents compared to eleven reagents required by other analysers. Further, the DxH 900 features one of the smallest footprints in its class, making it highly efficient in utilization of laboratory space. Many of the parameters available with the DxH 900 analyser are designed to directly impact patient care by addressing critical conditions, such as thrombocytopenia, anemia and leukopenia. Beckman Coulter is evaluating a hematology sepsis parameter that is part of a routinely ordered test in the emergency department, where earlier recognition and treatment of sepsis can begin. This test can be performed on the DxH 900 analyser (see below). The DxH 900 hematology analyser complements the recently announced DxH 520 system, and further expands Beckman Coulter’s hematology portfolio.


Contact form

Get in touch directly with the above supplier

Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: read our privacy policy.